INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | -60.0% | 6,988 | -22.7% | 0.00% | – |
| Q1 2022 | $10,000 | -50.0% | 9,038 | 0.0% | 0.00% | – |
| Q4 2021 | $20,000 | -35.5% | 9,038 | 0.0% | 0.00% | – |
| Q3 2021 | $31,000 | +14.8% | 9,038 | 0.0% | 0.00% | – |
| Q2 2021 | $27,000 | -95.1% | 9,038 | -97.4% | 0.00% | – |
| Q2 2017 | $548,000 | +1145.5% | 349,346 | +2430.0% | 0.00% | – |
| Q1 2017 | $44,000 | +76.0% | 13,808 | -25.5% | 0.00% | – |
| Q4 2016 | $25,000 | +127.3% | 18,534 | +154.6% | 0.00% | – |
| Q3 2016 | $11,000 | +10.0% | 7,279 | 0.0% | 0.00% | – |
| Q2 2016 | $10,000 | -74.4% | 7,279 | 0.0% | 0.00% | – |
| Q1 2016 | $39,000 | -30.4% | 7,279 | 0.0% | 0.00% | – |
| Q4 2015 | $56,000 | -5.1% | 7,279 | 0.0% | 0.00% | – |
| Q3 2015 | $59,000 | -22.4% | 7,279 | 0.0% | 0.00% | – |
| Q2 2015 | $76,000 | -28.3% | 7,279 | 0.0% | 0.00% | – |
| Q1 2015 | $106,000 | -14.5% | 7,279 | 0.0% | 0.00% | – |
| Q4 2014 | $124,000 | +18.1% | 7,279 | -5.0% | 0.00% | – |
| Q3 2014 | $105,000 | – | 7,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $819,180 | 0.18% |
| BVF INC/IL | 6,353,645 | $3,526,273 | 0.15% |
| Gratus Capital, LLC | 1,323,598 | $734,600 | 0.06% |
| Bleichroeder LP | 250,000 | $138,750 | 0.03% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $302,757 | 0.01% |
| Callan Capital, LLC | 158,500 | $87,968 | 0.01% |
| Polar Capital Holdings Plc | 2,071,242 | $1,149,539 | 0.01% |
| Virtu Financial LLC | 66,537 | $37 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $138,195 | 0.00% |
| Pacific Sage Partners, LLC | 17,500 | $9,713 | 0.00% |